Papers in Refereed Journals
Papers in Refereed Journals
1. Raz R, Akerman S, Keness Y, Colodner R, Reichman N, Miron D, Flatau E. The incidence of pneumococcal carrier state in children in Northern Israel and their susceptibility to penicillin. Israel Journal of Medical Sciences. 1993; vol.29-5: 308-310.
2. Raz R, Elhanan G, Colodner R, Reiss S, Schwartzman P, Tabenkin H, and Leshem Y. Penicillin V twice daily vs. four times daily in the treatment of streptococcal pharyngitis. Infectious Diseases in Clinical Practice. 1995; 1: 50-54.
3. Cohen RO, Colodner R, Ziv G, Keness Y. Isolation and antimicrobial susceptibility of obligate anaerobic bacteria recovered from the uteri of dairy cows with retained fetal membranes and postparturient endometritis. Journal of Veterinary Medicine. 1996; B43, 193-199.
4. Raz R, Miron D, Colodner R, Staler Z, Samara Z, Keness Y. A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. Archives of Internal Medicine. 1996; 156: 1109-1112.
5. Shalev E, Battino S, Weiner E, Colodner R, Keness Y. Ingestion of yoghurt containing lactobacillus acidophilus compared to pasteurized yoghurt as prophylaxis for recurrent candidal vaginitis and/or bacterial vaginosis. Archives of Family Medicine. 1996; 5: 593:596.
6. Sakran W, Raz R, Colodner R, Keness Y. Isolated susceptibility of Streptococcus pyogenes to three macrolides. Harefuah. 1997; 9: 365-366.
7. Raz R, Soboh S, Abu Much Z, Keness Y, Rafael C, Colodner R. Pneumococcal carriage in geriatric institute residents. Infectious Diseases in Clinical Practice - 1999; 8: 291-293.
8. Sakran W, Raz R, Levi Y, Colodner R, Koren A. Campylobacter bacteremia and pneumonia in splenectomized patients. European Journal of Clinical Microbiology and Infectious Diseases. 1999 Jul;18(7):496-8.
9. Bisharat N, Agmon V, Finkelstein R, Raz R, Ben-Dror G, Lerner L, Soboh S, Colodner R, Cameron D, Wykstra D, Swerdlow D, Farmer JJ. Clinical, epidemiological and microbiological features of a Vibrio vulnificusbiogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Lancet. 1999 Oct 23;354(9188):1421-4.
10. Miron D, Colodner R, Keness Y. Age-related seroprevalence of Cryptosporidium in Northern Israel. Israel Medical Association Journal 2000;2:343:345.
11. Colodner R, Chazan B, Kopelowitz J, Keness Y, Raz R. An anusual portal of entry of Vibrio vulnificus – evidence of its prolonged survival on the skin. Clinical Infectious Diseases. 2002 Mar 1;34(5):714-5
12. Colodner R, Keness Y. Evaluation of Dipstreak containing CNA-MacConkey agar, a new bedside urine culture device. Israel Medical Association Journal 2000 Jul;2(7):563-5.
13. Rakover Y, Smuskovitz A, Colodner R, Keness Y, Rosen G. Duration of the antibacterial effectiveness of gentamicin ear drops in external otitis. Journal of Laryngology and Otology, November 2000, 114:827-829.
14. Foxman B, Somsel P, Tallman P, Gillespie B, Raz R, Colodner R, Kandula D, Sobel JD. Urinary tract infection among women aged 40 to 65. Behavioral and sexual risk factors. Journal of Clinical Epidemiology 2001 Jul;54(7):710-8.
15. Colodner R, Keness Y, Chazan B, Raz R. Antimicrobial susceptibility of community-acquired uropathogens in Northern Israel. International Journal of Antimicrobial Agents, 2001; 18 (2):189-192.
16. Salim R, Ben-Shlomo I, Colodner R, Keness Y, Shalev E. Bacterial colonization of the uterine cervix and success rate in assisted reproduction: results of a prospective survey. Human Reproduction. 2002 Feb;17(2):337-40.
17. Marrs CF, Zhang L, Tallman P, Manning S, Somsel P, Raz R, Colodner R, Jantunen ME, Siitonen A, Saxen H, Foxman B. Variations in ten putative uropathogen virulence genes among urinary, fecal and periurethral Escherichia coli. Journal of Medical Microbiology. 2002 Feb;51(2):138-42.
18. Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, Lavi I, Stamm W. Empiric Use of Trimethoprim-Sulfamethoxazole (TMP-SMX) in the Treatment of Women with Uncomplicated Urinary Tract Infections, in a Geographical Area with a High Prevalence of TMP-SMX-Resistant Uropathogens. Clinical Infectious Diseases 2002 May 1;34(9):1165-9.
19. Genizi J, Miron D, Colodner R, Lumilsky D, Bykov S, Horowitz Y. Salmonella sacroiliitis and bacteremia in a child. Harefuah. 2002 Aug;141(8):685-8.
20. Smolkin V, Koren A, Raz R, Colodner R, Sakran W, Halevy R. Procalcitonin as a marker of acute pyelonephritis in infants and children. Pediatric Nephrology 2002; 17(6): 409-412.
21. Sakran W, Miron D, Halevy R, Colodner R, Smolkin V, Koren A. Community acquired urinary tract infection among hospitalized children in northern Israel: pathogens, susceptibility patterns and urinary tract anomalies. Harefuah 2003 Apr;142(4):249-52.
22. Raz R, Colodner R, Rohana Y, Battino S, Rottensterich E, Wasser I, Stamm W. Effectiveness of estriol containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clinical Infectious Diseases. 2003 Jun 1;36(11):1362-8.
23. Colodner R, Sakran W, Miron D, Teitler N, Khavalevsky E, Kopelowitz J. Listeria monocytogenes cross-contamination in a nursery. In press. American Journal of Infection Control 2003;31(5):322-4.
24. Miron D, Lev A, Colodner R, Merzel Y. Compartment syndrome of the calf as the initial manifestation of Vibrio Vulnificus associated severe infection in a child with congenital spherocytosis. The Pediatric Infectious Disease Journal 2003; 22(7):666-8.
25. Saliba WR, Goldstein LH, Raz R, Mader R, Colodner R, Elias MS. Subacute necrotizing fasciitis caused by gas-producing Staphylococcus aureus. European Journal of Clinical Microbiology and Infectious Diseases. 2003 Oct; 22(10): 612-4.
26. Mendelson G, Yearmack Y, Granot E, Ben-Israel J, Colodner R, Raz R. Staphylococcus aureus carrier state among elderly residents in a long-term care facility. Journal of the American Medical Directors Association 2003;4(3):125-7.
27. Chazan B, Shaabi M, Bishara E, Colodner R, Raz R. Clinical predictors of streptococcal pharingitis in adults. The Israel Medical Association Journal. June 2003;5:413-5.
28. Raz R, Sakran W, Chazan B, Colodner R, Kunin C. Long-term follow-up of women hospitalized for acute pyelonephritis. Clinical Infectious Diseases. 2003 Oct 15;37(8):1014-20.
29. Colodner R, Edelstein H, Chazan B, Raz R. Vaginal colonization by oral administered Lactobacillus rhamnosus-GG (LGG). The Israel Medical Association Journal. Nov 2003;5:767-9.
30. Colodner R, Raz R, Meir I, Lazarovich Z, Lerner L, Kopelowitz J, Keness Y, Sakran W, Ken-Dror S, Bisharat N. Identification of the new emerging pathogen Vibrio vulnificus biotype 3 using commercially-available phenotypic methods. Journal of Clinical Microbiology. 2004;42(9):4137-4140.
31. Sakran W, Valinsky L, Koren A, Bor N, Yishay R, Colodner R. Early onset of neonatal Streptococcus pneumoniae bacteremia and septic arthritis. Clinical Pediatrics. 2004;43(6)579-81.
32. Colodner R, Rock W, Chazan B, Keller N, Guy N, Raz R. Risk factors for the development of extended-spectrum beta-lactamases in non-hospitalized patients. European Journal of Clinical Microbiology and Infectious Diseases. March 2004;23(3):163-7.
33. Sakran W, Raz R, Chazan B, Koren A, Yishai R, Colodner R. Susceptibility of Streptococcus pyogenes to two macrolides in Northern Israel. International Journal of Antimicrobial Agents. 2004; 23(5):517-519.
34. Sakran W, Mazzawi S, Merzel Y, Colodner R. Streptococcal necrotizing fasciitis with toxic shock syndrome following cervical adenitis. International Journal of Pediatric Otorhinolaringology. Int J Pediatr Otorhinolaryngol. 2004 Sep;68(9):1209-13.
35. Colodner R, Raz R, Chazan B, Sakran W. Susceptibility pattern of ESBL-producing bacteria isolated from inpatients to five antimicrobial drugs in a community hospital in northern Israel. International Journal of Antimicrobial Agents. 2004; 24(4):409-410
36. Miron D, Torem M, Merom R, Colodner R. Azithromycin as an Alternative to Nalidixic Acid for Therapy of Childhood Shigellosis. The Pediatric Infectious Disease Journal. 2004 Apr; 23(4):367-8
37. Chazan B, Colodner R, Polacheck Y, Shoufani A, Rozenman D, Raz R. Cutaneous infection by Cylindrocarpon lichenicola in an immunocompetent patient. Journal of Travel Medicine. 2004 Sep-Oct;11(5):331-2.
38. Chazan B, Raz R, Sakran W, Colodner R. Improved antimicrobial susceptibility of community-acquired uropathogens in northern Israel (1995-1999-2002). Int J Antimicrob Agents. 2004 Jul;24(1):89-92.
39. Johnson JR, Kuskowski MA, O’Bryan TT, Colodner R, Raz R. Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli isolates from Israeli women with acute uncomplicated cystitis. Antimicrobial Agents and Chemotherapy. 2005 Jan;49(1):26-31.
40. Johnson JR, Murray AC, Kuskowski MA, Schubert S, Prere MF, Picard B, Colodner R, Raz R and the Trans-Global Initiative for Antimicrobial Resistance Analysis (TIARA) Investigators. Global Distribution and Characteristics of Escherichia coli Clonal Group A. Emerging Infectious Diseases. 2005 Jan;11(1):141-5.
41. Colodner R, Raz R. Extended-spectrum beta-lactamases: the end of cephalosporins? Israel Medical Association Journal. 2005; 7:336-338
42. Chen Y, Colodner R, Chazan B, Raz R. Pharyngotonsillitis due to Arcanobacterium haemolyticum in Northern Israel. Israel Medical Association Journal. 2005 Apr;7:236-237.
43. Sakran W, Makary H, Colodner R, Ashkenazi D, Rakover Y, Halevy R, Koren A. Acute otitis media in infants less than 12 weeks of age: clinical presentation, etiology and concomitant diseases. International Journal of Pediatric Otorhinolaringology. Accepted for publication August 2005.
44. Colodner R. Extended-spectrum beta-lactamases: a challenge for clinical microbiologists and infection control specialists. American Journal of Infection Control. 2005;33(2):104-107.
45. Raz R, Colodner R, Kunin CM. Who are you – Staphylococcus saprophyticus? Clinical Infectious Diseases. 2005. 40(6):896-8.
46. Johnson JR, Johnston B, Kuskowski MA, Colodner R, Raz R. Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype. Antimicrobial Agents and Chemotherapy. 2005; 49:4739-44.
47. Miron D, Horowitz Y, Lumelsky D, Hanania S, Colodner R. Dual pulmonary infection with Candida dubliniensis and Aspergillus fumigatus in a child with chronic granulomatous disease. Journal of Infection. 2005;50(1):72-5.
48. Raz R, Ben-Israel Y, Gronich D, Granot E, Colodner R, Visotzky I. Usefulness of blood cultures in the management of febrile patients in long-term care facilities. European Journal of Clinical Microbiology and Infectious Diseases. 2005 Nov;24(11):745-8.
49. Colodner R, Reznik B, Gal V, Yamazaki H, Hanaki H, Kubo R. Evaluation of a novel kit – Cica-Beta Test I – for the rapid detection of extended-spectrum beta-lactamases. European Journal of Clinical Microbiology and Infectious Diseases. 2006;25(1):49-51.
50. Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R. Are blood cultures necessary in the management of women with complicated pyelonephritis? Journal of Infection. 2006;53(4):235-40.
51. Colodner R, Eliasberg T, Chazan B, Raz R. Clinical significance of bacteriuria with low colony count of Enterococcus spp. European Journal of Clinical Microbiology and Infectious Diseases. (2006) 25:238-241.
52. Turgeman Y, Levahar P, Lavi I, Shneor A, Colodner R, Samra Z, Bloch L, Rosenfeld T. Adult calcific aortic stenosis and Chlamydia pneumoniae: the role of Chlamydia infection in valvular calcification. The Israel Medical Association Journal. 2006 Jul;8(7):464-8.
53. Colodner R, Ken-Dror S, Kavenshtock B, Chazan B, Raz R. Epidemiology and clinical characteristics of patients with Staphylococcus saprophyticus bacteriuria in Israel. Infection. 2006 Oct;34(5):278-281.
54. Nachum Z, Colodner R, Salim R, Gabarin D, Batino S, Shalev E. Probiotic yogurt for the prevention of bacterial vaginosis recurrence in pregnant women at risk of preterm labor. American Journal of Obstetrics and Gynecology. 2006;193(6): S192.
55. Colodner R, Samra Z, Keller N, Sprecher H, Block C, Peled N, Lazarovitch T, Bardenstein R, Schwartz-Harari O, Carmeli Y. First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp to antimicrobials in Israel. Diagnostic Microbiology and Infectious Diseases. 2007;57(2):201-205.
56. Chazan B, Kopelman D, Katz Z, Kniznik D, Chen Y, Colodner R, Raz R. Fournier’s gangrene (FG) as the initial presentation of HIV infection. International Journal of Infectious Diseases. 2007 Mar;11(2):184-185.
57. Rock W, Colodner R, Chazan B, Elias M, Raz R. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005). Israel Medical Association Journal. 2007:9:803-805.
58. Colodner R, Kometiani I, Chazan B, Raz R. Risk factors for community-acquired urinary tract infection due to quinolone-resistant Escherichia coli. Infection. 2008 Jan 12; Epub ahead of print.
59. Chazan B, Raz R, Shental Y, Sprecher H, Colodner R. Bacteremia and pyelonephritis caused by Lactobacillus jensenii in a patient with urolithiasis: a case report. Israel Medical Association Journal. 2008 Feb;10(2):164-5.
60. Davidovich T, Rimbroth S, Hazan B, Colodner R, Markel A. Recurrent septicemia and osteomyelitis caused by Pasteurella multocida in a patient with chronic lymphativ leukemia. Israel Medical Association Journal. 2008 (10):653-654.
61. Colodner R, Nuri Y, Chazan B, Raz R. Community-acquired and hospital-acquired candiduria: comparison of prevalence and clinical characteristics. European Journal of Clinical Microbiology and Infectious Diseases. 2008; 27(4):301-305.
62. Chazan B, Colodner R, Teitler N, Chen Y, Raz R. Varicella zoster virus in health care workers in northern Israel: seroprevalence and predictive value of history of varicella infection. Am J Infect Control. 2008 Aug;36(6):436-8.
63. Chazan B, Colodner R, Teitler N, Chen Y, Raz R. Varicella Zoster Virus in Health Care Workers in Northern Israel: Seroprevalence and Predictive Value of History of Varicella Infection. Accepted for publication at: American Journal of Infection Control, 2008;36(6):436-8.
64. Chazan B, Colodner R, Teitler N, Chen Y, Raz R. Varicella Zoster Virus in Health Care Workers in Northern Israel: Seroprevalence and Predictive Value of History of Varicella Infection. Accepted for publication at: American Journal of Infection Control, 2008;36(6):436-8.
65. Galayduyk N, Colodner R, Chazan B, Flatau E, Lavi I, Raz R. Adherence to guidelines on empiric use of antibiotics in the emergency room. Infection. 2008; 36(5):408-14.
66. Leavitt A, Chmelnitsky I, Colodner R, Ofek I, Carmeli Y, Navon-Venezia S. Ertapenem resistance among extended spectrum beta-lactamases producing Klebsiella pneumoniae. Journal of Clinical Microbiology. 2009;47(4): p.969-974.
67. Chazan B, Raz R, Teitler N, Nitzan O, Edelstein H, Colodner R. Epidemiology and susceptibility to antimicrobials in community, hospital and long-term-care-facility bacteremia in Northern Israel – a 6-Years Surveillance. Israel Medical Association Journal. 2009; 9:592-597.
68. Colodner R, Nitzan O, Chazan B, Edelstein H, Raz R. Mannose-binding lectin in pre-menopausal womed with recurrent urinary tract infections. Clinical Microbiology and Infection. 2009 Nov 2. [Epub ahead of print]
7